Safety and Effectiveness of Zemplar Injection in Decreasing iPTH Levels in Pediatric ESRD Subjects on Hemodialysis
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to see if Zemplar, a vitamin D medication, safely and
effectively decreases parathyroid hormone in children ages 2-20 with End Stage Renal Disease.